Malcolm J. Sheardown

2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: a Neuroprotectant for Cerebral Ischemia

Malcolm J. Sheardown, Elsebet Ø. Nielsen, Anker Jón Hansen et al. · Science · 1990 · 1.1K citations

Medicine, Neuroscience, Pharmacology +16

Functional characterization of agonists at recombinant human 5‐HT_2A, 5‐HT_2B and 5‐HT_2C receptors in CHO‐K1 cells

Richard H. Porter, Karen Benwell, Helen Lamb et al. · British Journal of Pharmacology · 1999 · 356 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Regional Changes in Interstitial K ⁺ and Ca ²⁺ Levels following Cortical Compression Contusion Trauma in Rats

Pelle Nilsson, Lars Hillered, Yngve Olsson et al. · Journal of Cerebral Blood Flow & Metabolism · 1993 · 276 citations · Full text

Medicine, Neurobiology, Neuroscience +15

AMPA, but not NMDA, receptor antagonism is neuroprotective in gerbil global ischaemia, even when delayed 24 h

Malcolm J. Sheardown, Peter D. Suzdak, Lars Nordholm · European Journal of Pharmacology · 1993 · 192 citations

Medicine, Neurobiology, Neuroscience +14

ZK200775: A phosphonate quinoxalinedione AMPA antagonist for neuroprotection in stroke and trauma

Lechosław Turski, Andreas Huth, Malcolm J. Sheardown et al. · Proceedings of the National Academy of Sciences · 1998 · 168 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +16